SHERECA HENDERSON: Open Payments
NPI 1730529579 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,650 in 141 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $636 · 2025 $2,650
Food & beverage: $2,650
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 31 | $691 |
| Teva Pharmaceuticals USA, Inc. | 45 | $638 |
| Janssen Pharmaceuticals, Inc | 19 | $605 |
| ABBVIE INC. | 32 | $436 |
| Otsuka America Pharmaceutical, Inc. | 9 | $185 |
| Alkermes, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: FANAPT, INVEGA SUSTENNA, AUSTEDO XR, VRAYLAR, UZEDY, REXULTI, SPRAVATO, INVEGA TRINZA.
Industry payments across OK — which companies pay providers there.
